Delivery Order SPE2DB20D1004-SPE2DB25F1700
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,008.18 firm fixed-price delivery order on August 25, 2025, for Oxcarbazepine 300 mg/5 ml suspension in a 250 ml container. This is a non-set-aside contract with an ultimate completion date of August 26, 2025, and performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,088 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), a neurological medication commonly used to treat seizure disorders and neuropathic pain. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-competitive set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support...
- On September 3, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,791.77 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 ml suspension in 250 ml quantities. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- The Defense Logistics Agency awarded a $1,161 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250mL of Oxcarbazepine 300mg/5mL suspension. As a prime contractor on an indefinite delivery/indefinite quantity pharmaceuticals contract, Amerisourcebergen will deliver the generic anti-seizure medication to a facility in Conshohocken, Pennsylvania by June 27, 2023 to support the Department of Defense's medical supply needs. No subcontractors or set aside designations were...
- The Defense Logistics Agency Troop Support Medical awarded a $1,107.35 firm fixed price delivery order to Amerisourcebergen Drug Corp for the supply of 250ml bottles of Oxcarbazepine 300 mg/5 ml suspension. The prime contractor, a division of Amerisourcebergen Corporation, will perform the contract from its location in Conshohocken, Pennsylvania. The order is to be completed by September 8, 2023 and was awarded under an existing Amerisourcebergen contract vehicle with the agency to supply...
- The Defense Logistics Agency awarded a $1,257.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 250ml bottles of the pharmaceutical product Oxcarbazepine 300 mg/5 ml suspension. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is three days, from August 18, 2023 through August 21, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $4,568.42 contract is for the supply of 250 ml bottles of the medication Oxcarbazepine 300 mg/5 ml suspension. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,025.75, is for the delivery of 4564543492 - Oxcarbazepine 300 mg/5 ml suspension, 250 ml. The contract has an ultimate completion date of May 9, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
- The Defense Logistics Agency Troop Support Medical awarded a $9,845.52 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to supply 4561533983 Oxcarbazepine 300 mg/5 ml susp 250ml. The place of performance will be Conshohocken, Pennsylvania. The contract period of performance spans from July 18, 2023 to July 19, 2023. No subcontractors or set aside designations were indicated. This delivery order was issued against an existing DLA medical product...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25F1700Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,958.79 to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine 300 mg/5 mL suspension in 250 mL quantities. The contract is a firm fixed price delivery order with no set-aside designation, competitively awarded on September 3, 2025, with an ultimate completion date of September 4, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the contractor to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company has demonstrated capability to fulfill federal requirements through open competition across a diverse portfolio of pharmaceutical products and medical supplies. Oxcarbazepine, an anticonvulsant medication, supports the Defense Health Agency's pharmaceutical supply needs for military healthcare operations globally. The firm fixed price structure and rapid completion timeline reflect standard operational efficiency in the military medical supply chain managed by DLA Troop Support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/3/25 |